Investor Notice: Robbins LLP Informs Investors of the Telix Pharmaceuticals Ltd. Securities Class Action
SAN DIEGO, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Telix Pharmaceuticals Ltd. (NASDAQ: TLX) securities between February 21, 2025 and …